Hillstream BioPharma, Inc. (NASDAQ:HILS – Get Free Report) shares were up 10.6% during mid-day trading on Wednesday . The company traded as high as $0.41 and last traded at $0.41. Approximately 195,636 shares traded hands during mid-day trading, a decline of 86% from the average daily volume of 1,388,685 shares. The stock had previously closed at $0.37.
Hillstream BioPharma Price Performance
The company’s 50 day simple moving average is $0.38 and its 200 day simple moving average is $0.38. The company has a market capitalization of $7.21 million, a PE ratio of -0.57 and a beta of 3.08.
Hillstream BioPharma Company Profile
Hillstream BioPharma, Inc, a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) and targeted immuno-oncology novel biologics for the treatment drug resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors.
Featured Articles
- Five stocks we like better than Hillstream BioPharma
- Investing in Commodities: What Are They? How to Invest in Them
- Lucid’s Stock Price is Still in Reverse: New Lows Are Coming
- Investing In Automotive Stocks
- Generac Powers Ahead on the Electrification Mega-Trend
- Investing in large cap stocks: Diving into big caps
- PulteGroup Wins and Wins More on Interest Rate Cuts
Receive News & Ratings for Hillstream BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hillstream BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
